Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial

Authors: Yu‐Pei Chen, Xu Liu, Qin Zhou, Kunyu Yang, Feng Jin, Xiaodong Zhu, Mei Shi, Guoqing Hu, Wei‐Han Hu, Yan Sun, Hong-Fen Wu, Hui Wu, Qin Lin, Hui Wang, Ye Tian, Ning Zhang, Xicheng Wang, Liangfang Shen, Zhengzheng Liu, Jing Huang, Xiuling Luo, Ling Li, Jian Zang, Qi Mei, Baomin Zheng, Dan Yue, Jing Xu, San‐Gang Wu, Yanxia Shi, Yan‐Ping Mao, Lei Chen, Wen‐Fei Li, Guan‐Qun Zhou, Rui Sun, Rui Guo, Yuan Zhang, Cheng Xu, Jia‐Wei Lv, Ying Guo, Huixia Feng, Ling‐Long Tang, Fang‐Yun Xie, Ying Sun, Jun Ma - The Lancet 2021 cited by 234